QT Imaging (QTI) Projected to Post Quarterly Earnings on Tuesday

QT Imaging (NASDAQ:QTI) will likely be announcing its results before the market opens on Tuesday, May 12th. Analysts expect the company to announce earnings of ($0.1350) per share and revenue of $6.4480 million for the quarter.

QT Imaging (NASDAQ:QTI) last issued its quarterly earnings data on Wednesday, February 18th. The company reported ($0.10) earnings per share for the quarter. The firm had revenue of $8.27 million for the quarter. On average, analysts expect QT Imaging to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

QT Imaging Stock Up 2.5%

Shares of NASDAQ:QTI traded up $0.17 during trading on Tuesday, hitting $6.70. 3,117 shares of the company were exchanged, compared to its average volume of 34,697. QT Imaging has a 12-month low of $0.65 and a 12-month high of $8.50. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.81 and a quick ratio of 2.17. The stock has a market capitalization of $80.62 million, a P/E ratio of -3.06 and a beta of 0.01. The firm’s 50 day moving average price is $6.41 and its 200-day moving average price is $5.93.

Analysts Set New Price Targets

Several research firms have recently weighed in on QTI. Lake Street Capital began coverage on QT Imaging in a report on Friday, January 30th. They issued a “buy” rating for the company. Zacks Research raised QT Imaging from a “strong sell” rating to a “hold” rating in a report on Monday, April 20th. Finally, Weiss Ratings assumed coverage on QT Imaging in a report on Thursday, January 29th. They issued a “sell (e+)” rating for the company. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold”.

About QT Imaging

QT Imaging Ltd. (NASDAQ: QTI) is a medical technology company specializing in the development and commercialization of advanced ultrasound imaging solutions. The company focuses on real-time volumetric imaging systems designed to enhance diagnostic capabilities in obstetrics, gynecology and other clinical applications. QT Imaging’s flagship Q.VIEW® system and associated software suite enable practitioners to capture, analyze and visualize high-resolution 3D/4D ultrasound images, offering improved workflow efficiency and enhanced patient care.

QT Imaging’s product portfolio includes proprietary transducers, imaging consoles and software platforms that can be integrated with existing ultrasound scanners from leading original equipment manufacturers.